Trial Profile

Phase 4 Study of the Effect of Human Recombinant Erythropoietin at the Time of Reperfusion in Patients With Acute Myocardial Infarction

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Epoetin alfa; Epoetin beta
Indications Myocardial infarction; Myocardial reperfusion injury
Focus Therapeutic Use
Acronyms EPO-in-AMI

Most Recent Events

02 Jun 2011 Results published in the International Journal of Cardiology.
21 Sep 2009 Results have been reported at the 21st Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
18 Jun 2009 Results presented at the 15th International Symposium on Atherosclerosis

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com